{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:02:45Z","timestamp":1779951765909,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100006286","name":"Kongelig Hofbuntmager Aage Bangs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF21OC0066694"],"award-info":[{"award-number":["NNF21OC0066694"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Herlev and Gentofte Research council"},{"DOI":"10.13039\/501100008267","name":"Kong Christian den Tiendes Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008267","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010346","name":"Else og Mogens Wedell Wedellsborgs Fond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","award":["LF-ST-21-500002"],"award-info":[{"award-number":["LF-ST-21-500002"]}],"id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s13555-026-01748-4","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T08:33:29Z","timestamp":1776414809000},"page":"2541-2555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early Proteomic Alterations in Non-segmental Vitiligo Skin Following Treatment with Topical Tacrolimus"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5553-3213","authenticated-orcid":false,"given":"Morten B.","family":"Haulrig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6524-6982","authenticated-orcid":false,"given":"Sonja","family":"Kabatnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4784-9680","authenticated-orcid":false,"given":"Lone","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7361-5845","authenticated-orcid":false,"given":"Marianne B.","family":"L\u00f8vendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3012-2645","authenticated-orcid":false,"given":"Beatrice","family":"Dyring-Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,17]]},"reference":[{"key":"1748_CR1","first-page":"1","volume":"3","author":"MB Haulrig","year":"2024","unstructured":"Haulrig MB, Al-Sofi R, Baskaran S, Bergmann MS, L\u00f8vendorf M, Dyring-Andersen B, et\u00a0al. The global epidemiology of vitiligo: a systematic review and meta-analysis of the incidence and prevalence. JEADV Clin Pract. 2024;3:1\u201310.","journal-title":"JEADV Clin Pract"},{"issue":"6","key":"1748_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s40257-021-00631-6","volume":"22","author":"K Ezzedine","year":"2021","unstructured":"Ezzedine K, Eleftheriadou V, Jones H, Bibeau K, Kuo FI, Sturm D, et\u00a0al. Psychosocial effects of vitiligo: a systematic literature review. Am J Clin Dermatol. 2021;22(6):757\u201374.","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"1748_CR3","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/pcmr.12949","volume":"34","author":"J Seneschal","year":"2021","unstructured":"Seneschal J, Boniface K, D\u2019Arino A, Picardo M. An update on vitiligo pathogenesis. Pigment Cell Melanoma Res. 2021;34(2):236\u201343.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"11","key":"1748_CR4","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1111\/jdv.19450","volume":"37","author":"J Seneschal","year":"2023","unstructured":"Seneschal J, Speeckaert R, Ta\u00efeb A, Wolkerstorfer A, Passeron T, Pandya AG, et\u00a0al. Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force\u2014Part 2: specific treatment recommendations. J Eur Acad Dermatology Venereol. 2023;37(11):2185\u201395.","journal-title":"J Eur Acad Dermatology Venereol"},{"issue":"4","key":"1748_CR5","first-page":"2","volume":"13","author":"J Seneschal","year":"2023","unstructured":"Seneschal J, Boniface K. Vitiligo: current therapies and future treatments. Dermatol Pract Concept. 2023;13(4):2\u20135.","journal-title":"Dermatol Pract Concept"},{"issue":"2","key":"1748_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.annder.2025.103352","volume":"152","author":"A Duplaine","year":"2025","unstructured":"Duplaine A, Tannous J, Seneschal J, Ezzedine K, Passeron T, Dupin N, et\u00a0al. Value of tacrolimus 0.1% in the treatment of vitiligo in the era of targeted therapy. Ann Dermatol Venereol. 2025;152(2):103352. https:\/\/doi.org\/10.1016\/j.annder.2025.103352.","journal-title":"Ann Dermatol Venereol"},{"key":"1748_CR7","first-page":"1","volume":"4","author":"H Mehta","year":"2025","unstructured":"Mehta H, Bishnoi A, Parsad D, Kumaran MS, Vinay K. Comparative efficacy of topical tofacitinib versus topical tacrolimus in the treatment of localized vitiligo: a randomized, investigator-blinded, intraindividual trial. Br J Dermatol. 2025;4:1\u20138.","journal-title":"Br J Dermatol."},{"key":"1748_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031465","author":"K Tsuda","year":"2012","unstructured":"Tsuda K, Yamanaka K, Kitagawa H, Akeda T, Naka M, Niwa K, et\u00a0al. Calcineurin inhibitors suppress cytokine production from memory T cells and differentiation of na\u00efve T cells into cytokine-producing mature T cells. PLoS ONE. 2012. https:\/\/doi.org\/10.1371\/journal.pone.0031465.","journal-title":"PLoS ONE"},{"issue":"3","key":"1748_CR9","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1111\/j.1365-2133.2009.09217.x","volume":"161","author":"ZA Taher","year":"2009","unstructured":"Taher ZA, Lauzon G, Maguiness S, Dytoc MT. Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus. Br J Dermatol. 2009;161(3):654\u20139.","journal-title":"Br J Dermatol"},{"issue":"1","key":"1748_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","volume":"51","author":"PE Grimes","year":"2004","unstructured":"Grimes PE, Morris R, Avaniss-Aghajani E, Soriano T, Meraz M, Metzger A. Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines. J Am Acad Dermatol. 2004;51(1):52\u201361.","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"1748_CR11","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1001\/jamadermatol.2019.0696","volume":"155","author":"JH Lee","year":"2019","unstructured":"Lee JH, Kwon HS, Jung HM, Lee H, Kim GM, Yim HW, et\u00a0al. Treatment outcomes of topical calcineurin inhibitor therapy for patients with vitiligo: a systematic review and meta-analysis. JAMA Dermatol. 2019;155(8):929\u201338.","journal-title":"JAMA Dermatol"},{"key":"1748_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nature19949","volume":"537","author":"R Aebersold","year":"2016","unstructured":"Aebersold R, Mann M. Mass-spectrometric exploration of proteome structure and function. Nature. 2016;537:347\u201355.","journal-title":"Nature"},{"issue":"5","key":"1748_CR13","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1016\/j.jaci.2025.01.020","volume":"155","author":"E Goleva","year":"2025","unstructured":"Goleva E, Berdyshev E, Kreimer S, Reisz JA, D\u2019Alessandro A, Bronova I, et\u00a0al. Longitudinal integrated proteomic and metabolomic skin changes in patients with atopic dermatitis treated with dupilumab. J Allergy Clin Immunol. 2025;155(5):1536\u201346. https:\/\/doi.org\/10.1016\/j.jaci.2025.01.020.","journal-title":"J Allergy Clin Immunol"},{"key":"1748_CR14","doi-asserted-by":"publisher","unstructured":"Nordmann TM, Anderton H, Hasegawa A, Schweizer L, Zhang P, Stadler PC, et al. Spatial proteomics identifies JAKi as treatment for a lethal skin disease. Vol. 635, Nature. Springer US; 2024. 1001\u20131009 p. https:\/\/doi.org\/10.1038\/s41586-024-08061-0.","DOI":"10.1038\/s41586-024-08061-0"},{"key":"1748_CR15","unstructured":"Ouwerkerk W, Narayan VS, Chielie S, van Uden NOP, Schneider MA, Hillenbrand R, et al. Immune and biological changes during treatment in patients with non-segmental vitiligo and their relation to repigmentation. J Invest Dermatol. 2025;1\u201312."},{"issue":"Suppl 1","key":"1748_CR16","doi-asserted-by":"publisher","first-page":"S96","DOI":"10.1093\/bioinformatics\/18.suppl_1.S96","volume":"18","author":"W Huber","year":"2002","unstructured":"Huber W, von Heydebreck A, S\u00fcltmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics. 2002;18(Suppl 1):S96-104.","journal-title":"Bioinformatics"},{"issue":"D1","key":"1748_CR17","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, et\u00a0al. STRING v11: Protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 2019;47(D1):D607\u201313.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1748_CR18","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/exd.12069","volume":"22","author":"D Janson","year":"2013","unstructured":"Janson D, Saintigny G, Mah\u00e9 C, El Ghalbzouri A. Papillary fibroblasts differentiate into reticular fibroblasts after prolonged in vitro culture. Exp Dermatol. 2013;22(1):48\u201353.","journal-title":"Exp Dermatol"},{"issue":"11","key":"1748_CR19","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1038\/jid.2012.192","volume":"132","author":"DG Janson","year":"2012","unstructured":"Janson DG, Saintigny G, Van Adrichem A, Mah\u00e9 C, El Ghalbzouri A. Different gene expression patterns in human papillary and reticular fibroblasts. J Invest Dermatol. 2012;132(11):2565\u201372.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"1748_CR20","doi-asserted-by":"publisher","first-page":"7288","DOI":"10.1074\/jbc.M109.070573","volume":"285","author":"B Bellei","year":"2010","unstructured":"Bellei B, Maresca V, Flori E, Pitisci A, Larue L, Picardo M. P38 regulates pigmentation via proteasomal degradation of tyrosinase. J Biol Chem. 2010;285(10):7288\u201399.","journal-title":"J Biol Chem"},{"issue":"52","key":"1748_CR21","doi-asserted-by":"publisher","first-page":"39891","DOI":"10.1074\/jbc.M608155200","volume":"281","author":"T Kajino","year":"2006","unstructured":"Kajino T, Ren H, Iemura SI, Natsume T, Stefansson B, Brautigan DL, et\u00a0al. Protein phosphatase 6 down-regulates TAK1 kinase activation in the IL-1 signaling pathway. J Biol Chem. 2006;281(52):39891\u20136. https:\/\/doi.org\/10.1074\/jbc.M608155200.","journal-title":"J Biol Chem"},{"issue":"3","key":"1748_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.108299","volume":"301","author":"N Nishida","year":"2025","unstructured":"Nishida N, Otsu M, Mizutani Y, Ishitsuka A, Mizukami Y, Inoue S. The glycoprotein GPNMB protects against oxidative stress through enhanced PI3K\/AKT signaling in epidermal keratinocytes. J Biol Chem. 2025;301(3):108299. https:\/\/doi.org\/10.1016\/j.jbc.2025.108299.","journal-title":"J Biol Chem"},{"issue":"1","key":"1748_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-61931-1","volume":"10","author":"KB Biswas","year":"2020","unstructured":"Biswas KB, Takahashi A, Mizutani Y, Takayama S, Ishitsuka A, Yang L, et\u00a0al. GPNMB is expressed in human epidermal keratinocytes but disappears in the vitiligo lesional skin. Sci Rep. 2020;10(1):1\u201311.","journal-title":"Sci Rep"},{"issue":"5","key":"1748_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jid.2019.09.017","volume":"140","author":"LY Chen","year":"2020","unstructured":"Chen LY, Lin KR, Chen YJ, Chiang YJ, Ho KC, Shen LF, et\u00a0al. Palmitoyl acyltransferase activity of ZDHHC13 regulates skin barrier development partly by controlling PADi3 and TGM1 protein stability. J Invest Dermatol. 2020;140(5):959-970.e3. https:\/\/doi.org\/10.1016\/j.jid.2019.09.017.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1748_CR25","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/path.4360","volume":"233","author":"S Roy","year":"2014","unstructured":"Roy S, Elgharably H, Sinha M, Ganesh K, Chaney S, Mann E, et\u00a0al. Mixed-species biofilm compromises wound healing by disrupting epidermal barrier function. J Pathol. 2014;233(4):331\u201343.","journal-title":"J Pathol"},{"issue":"6","key":"1748_CR26","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1111\/j.0022-202X.2005.23973.x","volume":"125","author":"J Arredondo","year":"2005","unstructured":"Arredondo J, Chernyavsky AI, Webber RJ, Grando SA. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol. 2005;125(6):1236\u201341. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23973.x.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"1748_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-025-01143-9","volume":"32","author":"M Chen","year":"2025","unstructured":"Chen M, Wang Y, Wang M, Xu S, Tan Z, Cai Y, et\u00a0al. Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes. J Biomed Sci. 2025;32(1):1\u201316.","journal-title":"J Biomed Sci"},{"issue":"5","key":"1748_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1172\/JCI89867","volume":"128","author":"T Vogl","year":"2018","unstructured":"Vogl T, Stratis A, Wixler V, V\u00f6ller T, Thurainayagam S, Jorch SK, et\u00a0al. Autoinhibitory regulation of S100A8\/S100A9 alarmin activity locally restricts sterile inflammation. J Clin Invest. 2018;128(5):1852\u201366.","journal-title":"J Clin Invest"},{"issue":"4","key":"1748_CR29","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1016\/j.jaci.2016.10.021","volume":"139","author":"Y Liang","year":"2017","unstructured":"Liang Y, Xing X, Beamer MA, Swindell WR, Sarkar MK, Roberts LW, et\u00a0al. Six-transmembrane epithelial antigens of the prostate comprise a novel inflammatory nexus in patients with pustular skin disorders. J Allergy Clin Immunol. 2017;139(4):1217\u201327. https:\/\/doi.org\/10.1016\/j.jaci.2016.10.021.","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"1748_CR30","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1210\/en.2010-1481","volume":"152","author":"N Kanda","year":"2011","unstructured":"Kanda N, Hau CS, Tada Y, Tatsuta A, Sato S, Watanabe S. Visfatin enhances CXCL8, CXCL10, and CCL20 production in human keratinocytes. Endocrinology. 2011;152(8):3155\u201364.","journal-title":"Endocrinology"},{"issue":"7","key":"1748_CR31","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.jid.2016.03.022","volume":"136","author":"N Jumper","year":"2016","unstructured":"Jumper N, Hodgkinson T, Arscott G, Har-Shai Y, Paus R, Bayat A. The aldo-keto reductase AKR1B10 is up-regulated in keloid epidermis, implicating retinoic acid pathway dysregulation in the pathogenesis of keloid disease. J Invest Dermatol. 2016;136(7):1500\u201312. https:\/\/doi.org\/10.1016\/j.jid.2016.03.022.","journal-title":"J Invest Dermatol"},{"key":"1748_CR32","doi-asserted-by":"publisher","DOI":"10.1111\/pcmr.70032","author":"A Bishnoi","year":"2025","unstructured":"Bishnoi A, Arunima A, Vinay K, Kumaran MS, Parsad D. SASH1 Mutations and hereditary disorders of pigmentation: review of literature. Pigment Cell Melanoma Res. 2025. https:\/\/doi.org\/10.1111\/pcmr.70032.","journal-title":"Pigment Cell Melanoma Res"},{"issue":"11 NOVEMBER","key":"1748_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0290358","volume":"18","author":"SP Jin","year":"2023","unstructured":"Jin SP, Suh JH, Kim CE, Oh IG, Seo EY, Kim MK, et\u00a0al. Functionally similar genes exhibit comparable\/similar time-course expression kinetics in the UV-induced photoaged mouse model. PLoS ONE. 2023;18(11 NOVEMBER):1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0290358.","journal-title":"PLoS ONE"},{"issue":"16","key":"1748_CR34","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1093\/hmg\/ddr215","volume":"20","author":"MJ Bijlmakers","year":"2011","unstructured":"Bijlmakers MJ, Kanneganti SK, Barker JN, Trembath RC, Capon F. Functional analysis of the RNF114 psoriasis susceptibility gene implicates innate immune responses to double-stranded RNA in disease pathogenesis. Hum Mol Genet. 2011;20(16):3129\u201337.","journal-title":"Hum Mol Genet"},{"issue":"5","key":"1748_CR35","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/nsmb.3010","volume":"22","author":"X Zhang","year":"2015","unstructured":"Zhang X, Gao X, Coots RA, Conn CS, Liu B, Qian SB. Translational control of the cytosolic stress response by mitochondrial ribosomal protein L18. Nat Struct Mol Biol. 2015;22(5):404\u201310.","journal-title":"Nat Struct Mol Biol"},{"issue":"8","key":"1748_CR36","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1016\/j.celrep.2017.07.056","volume":"20","author":"M Xia","year":"2017","unstructured":"Xia M, Chen K, Yao X, Xu Y, Yao J, Yan J, et\u00a0al. Mediator MED23 links pigmentation and DNA repair through the transcription factor MITF. Cell Rep. 2017;20(8):1794\u2013804. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.056.","journal-title":"Cell Rep"},{"issue":"15","key":"1748_CR37","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1016\/j.cub.2025.06.031","volume":"35","author":"PS Goff","year":"2025","unstructured":"Goff PS, Patel S, Harper DC, Carter T, Marks MS, Sviderskaya EV. Reprogramming of endolysosomes for melanogenesis in BLOC-1-deficient melanocytes. Curr Biol. 2025;35(15):3570-3586.e7. https:\/\/doi.org\/10.1016\/j.cub.2025.06.031.","journal-title":"Curr Biol"},{"issue":"7","key":"1748_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/embj.2021109470","volume":"41","author":"KM McAndrews","year":"2022","unstructured":"McAndrews KM, Miyake T, Ehsanipour EA, Kelly PJ, Becker LM, McGrail DJ, et\u00a0al. Dermal \u03b1SMA + myofibroblasts orchestrate skin wound repair via \u03b21 integrin and independent of type I collagen production. EMBO J. 2022;41(7):1\u201317.","journal-title":"EMBO J"},{"issue":"8","key":"1748_CR39","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jid.2024.02.007","volume":"144","author":"Y Wu","year":"2024","unstructured":"Wu Y, Yang Y, Lin Y, Ding Y, Liu Z, Xiang L, et\u00a0al. Emerging role of fibroblasts in vitiligo: a formerly underestimated rising star. J Invest Dermatol. 2024;144(8):1696\u2013706. https:\/\/doi.org\/10.1016\/j.jid.2024.02.007.","journal-title":"J Invest Dermatol"},{"issue":"4","key":"1748_CR40","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/exd.14702","volume":"32","author":"R Gupta","year":"2023","unstructured":"Gupta R, Misri R, Gupta A, Chowdhary M, Singh A. Genome-wide profiling reveals pervasive transcriptional alterations in fibroblasts derived from lesional skin in vitiligo including a reduced potential to proliferate. Exp Dermatol. 2023;32(4):331\u201340.","journal-title":"Exp Dermatol"},{"issue":"2","key":"1748_CR41","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","volume":"138","author":"D Kovacs","year":"2018","unstructured":"Kovacs D, Bastonini E, Ottaviani M, Cota C, Migliano E, Dell\u2019Anna ML, et\u00a0al. Vitiligo skin: exploring the dermal compartment. J Invest Dermatol. 2018;138(2):394\u2013404. https:\/\/doi.org\/10.1016\/j.jid.2017.06.033.","journal-title":"J Invest Dermatol"},{"issue":"13","key":"1748_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/jci.insight.154585","volume":"7","author":"J Shiu","year":"2022","unstructured":"Shiu J, Zhang L, Lentsch G, Flesher JL, Jin S, Polleys C, et\u00a0al. Multimodal analyses of vitiligo skin identifies tissue characteristics of stable disease. JCI Insight. 2022;7(13):1\u201319.","journal-title":"JCI Insight"},{"issue":"February","key":"1748_CR43","first-page":"1","volume":"14","author":"R Speeckaert","year":"2023","unstructured":"Speeckaert R, Belpaire A, Speeckaert MM, van Geel N. A meta-analysis of chemokines in vitiligo: recruiting immune cells towards melanocytes. Front Immunol. 2023;14(February):1\u20138.","journal-title":"Front Immunol"},{"issue":"2","key":"1748_CR44","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1590\/abd1806-4841.20164012","volume":"91","author":"A Sisti","year":"2016","unstructured":"Sisti A, Sisti G, Oranges CM. Effectiveness and safety of topical tacrolimus monotherapy for repigmentation in vitiligo: a comprehensive literature review. An Bras Dermatol. 2016;91(2):187\u201395.","journal-title":"An Bras Dermatol"},{"issue":"3","key":"1748_CR45","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jdermsci.2023.10.003","volume":"112","author":"X Du","year":"2023","unstructured":"Du X, Che D, Peng B, Zheng Y, Hao Y, Jia T, et\u00a0al. Dual effect of tacrolimus on mast cell\u2013mediated allergy and inflammation through Mas-related G protein-coupled receptor X2. J Dermatol Sci. 2023;112(3):128\u201337. https:\/\/doi.org\/10.1016\/j.jdermsci.2023.10.003.","journal-title":"J Dermatol Sci"},{"issue":"March","key":"1748_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep27915","volume":"6","author":"R Rodrigues-Diez","year":"2016","unstructured":"Rodrigues-Diez R, Gonz\u00e1lez-Guerrero C, Oca\u00f1a-Salceda C, Rodrigues-Diez RR, Egido J, Ortiz A, et\u00a0al. Calcineurin inhibitors cyclosporine A and tacrolimus induce vascular inflammation and endothelial activation through TLR4 signaling. Sci Rep. 2016;6(March):1\u201316. https:\/\/doi.org\/10.1038\/srep27915.","journal-title":"Sci Rep"},{"key":"1748_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2025.05.002","author":"LBP M\u00f8ller","year":"2025","unstructured":"M\u00f8ller LBP, Kromann B, Kabatnik S, Hjortlund JH, Haulrig MB, S\u00f8lberg JBK, et\u00a0al. Spatial proteomic profiling reveals increased levels of cholesterol synthesis proteins in psoriasis vulgaris. J Invest Dermatol. 2025. https:\/\/doi.org\/10.1016\/j.jid.2025.05.002.","journal-title":"J Invest Dermatol"},{"issue":"5","key":"1748_CR48","first-page":"541","volume":"13","author":"X Zhou","year":"2010","unstructured":"Zhou X, Fragala MS, McElhaney JE, Kuchel GA. Conceptual and methodological issues relevant to cytokine and inflammatory marker measurements in clinical research. Curr Opin Clin Nutr Metab Care. 2010;13(5):541\u20137.","journal-title":"Curr Opin Clin Nutr Metab Care"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01748-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01748-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:18:26Z","timestamp":1779949106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01748-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,17]]},"references-count":48,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1748"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01748-4","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,17]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Equal contribution updated.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Lone Skov has been an advisor, investigator, and speaker for Abbvie, Eli Lilly, Novartis, Sanofi, LEO Pharma, BMS, UCB, Incyte, Stada, Takeda, Pfizer and Almirall, unrelated to the submitted work. Lone Skov reports nonfinancial support from grants from Almirall, Novartis, Janssen, BMS, Sanofi and UCB. Morten Bahrt Haulrig, Sonja Kabatnik, Beatrice Dyring-Andersen and Marianne B. L\u00f8vendorf have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study was approved by the Ethics Committee of the Danish Capital Region \u200b(H-19036270) and the Danish Data Protection Agency, and it followed the principles of the Declaration of Helsinki II.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}